Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients
Gian Matteo Rigolin, Antonio Cuneo(Arcispedale Sant'Anna), Maurizio Cavallari(Arcispedale Sant'Anna), Manuela Ferracin(University of Ferrara), Elena Saccenti(University of Ferrara), Francesco Cavazzini(Arcispedale Sant'Anna), Francesca Cibien(University of Ferrara), Olga Sofritti(University of Ferrara), Laura Lupini(University of Ferrara), Lara Rizzotto, Enrico Lista(Arcispedale Sant'Anna), Barbara Zagatti(University of Ferrara), Giulia Daghia(University of Ferrara), Maria Ciccone(Arcispedale Sant'Anna), Massimo Negrini(University of Ferrara), Cristian Bassi(University of Ferrara), Sara Martinelli(University of Ferrara), Luca Formigaro(Arcispedale Sant'Anna)
Cited by 12
Related Papers
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells
|Experimental Hematology|2008|254
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
|Blood|2015|215
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
|Blood|2019|215
Oncogenic Role of <i>miR-483-3p</i> at the <i>IGF2/483</i> Locus
|Cancer Research|2010|213